Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 4/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31295174 | 0.92 | CYP2D6 (0.60) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295242 | 0.92 | CYP2D6 (0.60) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295360 | 0.92 | CYP2D6 (0.60) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295222 | 0.77 | CCR2 (0.43) | ADRA1DCYP2D6SLC6A4 | |
| SCHEMBL31295270 | 0.74 | ADRA1D (0.57) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295171 | 0.73 | HTR2A (0.44) | ADRA1DCYP2D6 | |
| SCHEMBL31295233 | 0.72 | ADRA1D (0.55) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295322 | 0.72 | CYP2D6 (0.57) | ADRA1DCYP2D6SLC6A4KDM4EATM | |
| SCHEMBL31295196 | 0.72 | HTR1A (0.50) | ADRA1DSLC6A4KDM4EATMHTR1A | |
| SCHEMBL31295206 | 0.70 | CYP2D6 (0.60) | ADRA1DCYP2D6SLC6A4KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119698412-A | 5-HT2A receptor agonist, and preparation method and application thereof | 上海翊石医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| WO-2025021120-A1 | 5-HT2A RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翊石医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |